Additionally, the increased migration of nasopharyngeal carcinoma cells, induced by CCL18 from the supernatants of ISG15-treated macrophages, was significantly reduced following treatment with this LFA-1 inhibitor (127). The gene discussed is ISG15; the disease is nasopharyngeal carcinoma.